These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18606054)

  • 1. The relationship between fibromyalgia and major depressive disorder: a comprehensive review.
    Pae CU; Luyten P; Marks DM; Han C; Park SH; Patkar AA; Masand PS; Van Houdenhove B
    Curr Med Res Opin; 2008 Aug; 24(8):2359-71. PubMed ID: 18606054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder.
    Arnold LM; Hudson JI; Wang F; Wohlreich MM; Prakash A; Kajdasz DK; Chappell AS
    Clin J Pain; 2009; 25(6):461-8. PubMed ID: 19542792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibromyalgia--management of a misunderstood disorder.
    Peterson EL
    J Am Acad Nurse Pract; 2007 Jul; 19(7):341-8. PubMed ID: 17680899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Family study of fibromyalgia.
    Arnold LM; Hudson JI; Hess EV; Ware AE; Fritz DA; Auchenbach MB; Starck LO; Keck PE
    Arthritis Rheum; 2004 Mar; 50(3):944-52. PubMed ID: 15022338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibromyalgia and psychiatric disorders.
    Fietta P; Fietta P; Manganelli P
    Acta Biomed; 2007 Aug; 78(2):88-95. PubMed ID: 17933276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. V. Complementary and alternative medicine treatments.
    Ravindran AV; Lam RW; Filteau MJ; Lespérance F; Kennedy SH; Parikh SV; Patten SB;
    J Affect Disord; 2009 Oct; 117 Suppl 1():S54-64. PubMed ID: 19666194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. II. Psychotherapy alone or in combination with antidepressant medication.
    Parikh SV; Segal ZV; Grigoriadis S; Ravindran AV; Kennedy SH; Lam RW; Patten SB;
    J Affect Disord; 2009 Oct; 117 Suppl 1():S15-25. PubMed ID: 19682749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major depressive disorder: remission of associated symptoms.
    Trivedi MH
    J Clin Psychiatry; 2006; 67 Suppl 6():27-32. PubMed ID: 16848674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychomotor functioning in chronic fatigue syndrome and major depressive disorder: a comparative study.
    Schrijvers D; Van Den Eede F; Maas Y; Cosyns P; Hulstijn W; Sabbe BG
    J Affect Disord; 2009 May; 115(1-2):46-53. PubMed ID: 18817977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New approaches to the pharmacological management of major depressive disorder.
    Witkin JM; Li X
    Adv Pharmacol; 2009; 57():347-79. PubMed ID: 20230766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the relationship between depression and fibromyalgia syndrome: why aren't all patients depressed?
    Okifuji A; Turk DC; Sherman JJ
    J Rheumatol; 2000 Jan; 27(1):212-9. PubMed ID: 10648041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A deficit in peripheral serotonin levels in major depressive disorder but not in chronic widespread pain.
    Paul-Savoie E; Potvin S; Daigle K; Normand E; Corbin JF; Gagnon R; Marchand S
    Clin J Pain; 2011; 27(6):529-34. PubMed ID: 21415718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity.
    Zimmermann P; Brückl T; Nocon A; Pfister H; Lieb R; Wittchen HU; Holsboer F; Angst J
    Arch Gen Psychiatry; 2009 Dec; 66(12):1341-52. PubMed ID: 19996039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of pain on outcomes in a trial of duloxetine treatment of major depressive disorder.
    Arnold LM; Meyers AL; Sunderajan P; Montano CB; Kass E; Trivedi M; Wohlreich MM
    Ann Clin Psychiatry; 2008; 20(4):187-93. PubMed ID: 19034749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognizing and Treating Major Depression in Fibromyalgia: A Narrative Primer for the Non-Psychiatrist.
    Munipalli B; Chauhan M; Morris AM; Ahmad R; Fatima M; Allman ME; Niazi SK; Bruce BK
    J Prim Care Community Health; 2024; 15():21501319241281221. PubMed ID: 39279389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptom clusters in fibromyalgia: potential utility in patient assessment and treatment evaluation.
    Rutledge DN; Mouttapa M; Wood PB
    Nurs Res; 2009; 58(5):359-67. PubMed ID: 19752676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment.
    Liou YJ; Chen TJ; Tsai SJ; Yu YW; Cheng CY; Hong CJ
    Pharmacogenet Genomics; 2009 Oct; 19(10):735-41. PubMed ID: 19741570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of antipsychotics in the treatment of major depressive disorder in the U.S. Department of Veterans Affairs.
    Mohamed S; Leslie DL; Rosenheck RA
    J Clin Psychiatry; 2009 Jun; 70(6):906-12. PubMed ID: 19422760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desvenlafaxine succinate for major depressive disorder: a critical review of the evidence.
    Kamath J; Handratta V
    Expert Rev Neurother; 2008 Dec; 8(12):1787-97. PubMed ID: 19086875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of escitalopram treatment on Quality of Life Enjoyment and Satisfaction Questionnaire scores in major depressive disorder and generalized anxiety disorder.
    Demyttenaere K; Andersen HF; Reines EH
    Int Clin Psychopharmacol; 2008 Sep; 23(5):276-86. PubMed ID: 18703937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.